A recent report showed that periodic administration of high doses of tannic acid (not condensed) prevents cognitive impairment in an AD-like model induced by lipopolysaccharide intraperitoneal injections (the major activator of the proinflammatory TLR4 signaling pathway) [29]. This evidence concerns the gene TLR4 and Alzheimer disease.